Matrix Gemini LIMS at Work in Cancer Research Trials

The Roy Castle Lung Cancer Foundation (RCLCF) is a UK wide charity, dedicated to the defeat of lung cancer. It funds basic science research, tobacco control initiatives and work in lung cancer patient information, support and advocacy. RCLCF works towards defeating lung cancer through research, campaigning and education and gives practical and emotional support for patients and all those affected by lung cancer and smoking. It also enables children and young people to make informed decisions about smoking and the tobacco industry.

Clinical trial research facilities like RCLCF and computer systems that involve the storage of Human Tissue Samples need to be compliant with the Human Tissue Act (2006).

Key objectives for implementing a LIMS at RCLCF were to

• Comply with current and future regulatory requirements and associated audits

• Improve the method for booking in samples

• Improve the logging of booked out samples and their usage

• Result in a user friendly system that makes sample editing and auditing easy to use

• Select a system that could be easily configured to meet current and future needs

• Select a system with a track record of backward compatibility and ease of upgrade

• Purchase a compliant system that RCLCF staff could configure for themselves

Autoscribe Limited is a world leader in the development and supply of innovative configuration tools within the LIMS market and today our Matrix Gemini LIMS software is setting new standards of flexibility and adaptability. This was the system chosen for the application as described above.

For a full copy of the article please send e-mail to matrix@autoscribe.co.uk

Autoscribe – Number One for Customer Satisfaction in LIMS!

For more information on Autoscribe, and its products, visit our web site at www.autoscribelims.com

Further Enquiries to:

Autoscribe UK Ltd.
Wellington House
Riseley Business Park
Basingstoke Road
Riseley
Reading
Berkshire, RG7 1NW, UK

Telephone: +44 (0) 118 984 0610
Fax: +44 (0) 118 984 0611